21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

Charles E. Geyer, Gong Tang, Eleftherios P. Mamounas, Priya Rastogi, Soonmyung Paik, Steven Shak, Frederick L. Baehner, Michael Crager, D. Lawrence Wickerham, Joseph P. Costantino, Norman Wolmark

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of '21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences